Navigation Links
InterMune Presents Research on ITMN-191 in Hepatitis C at EASL,Annual Meeting

Presentations include preclinical data for potential combination therapies and details of N3/4A protease sequence variations after ITMN-191 exposure

BARCELONA, Spain, April 11, 2007 /PRNewswire-FirstCall/ -- InterMune, Inc. announced today the presentation of findings from three in vitro experiments concerning its HCV protease inhibitor ITMN-191, alone or in combination with other compounds, at the 42nd Annual Meeting of the European Association for the Study of the Liver in Barcelona, Spain.

The first presentation concerned the activity of ITMN-191 alone or in combination with PEG-IFN-alfa-2a (Roche's Pegasys(R)) in an in vitro model of HCV clearance. These experiments explored the concentrations of ITMN-191 needed to achieve HCV replicon clearance from a human liver cell line during a two-week course of treatment. Complete clearance of replicon RNA was achieved with a 14-day treatment of only 45 nM of ITMN-191; a concentration well below that achieved in the liver of animal species following twice-daily oral dosing. Combination of the minimum human plasma concentration of PEG-IFN-alfa-2a with 15 nM of ITMN-191 also promoted durable replicon clearance, indicating clinical investigation of the anti-HCV activity of the two agents in combination is warranted.

The second experiment described the synergistic antiviral activity of ITMN-191 with Roche's R1479, an inhibitor of the HCV NS5B polymerase. The in vitro antiviral activity of each agent was enhanced when used in combination. Additionally, the replicon with reduced sensitivity to ITMN-191 remained fully sensitive to R1479, suggesting that the combination of these two agents could decrease the potential for the development of drug-resistant HCV variants in monotherapy treatments.

"With our continued research, we are better understanding the antiviral effects of ITMN-191, alone and in combination with other agents, such as polymerase inhibi
'"/>




Page: 1 2 3 4

Related medicine technology :

1. InterMune Presents Research on ITMN-191 in Hepatitis C at Digestive Disease Week Meeting
2. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
3. European Society for Medical Oncology (ESMO) Presents Data from the Clinical Trial of MediGenes Cancer-Killing Virus in Press Conference
4. Cytogen Presents Phase 1 Data Showing Promising Antitumor Activity and Safety Profile of Quadramet at International Myeloma Workshop
5. SemBioSys Presents Positive Insulin Data at the American Diabetes Association Conference
6. Tranzyme Pharma Presents Initial Phase IIa Data for its Novel Ghrelin Agonist, TZP-101, in Patients with Diabetic Gastroparesis
7. Novagali Pharma Presents at AACO the Results of its Pivotal Phase III Clinical Trial of Vekacia in Children Suffering From Vernal Keratoconjunctivitis
8. BioLife Solutions Presents Data on CryoStor at International Society for Cellular Therapy Annual Meeting
9. Genaera Presents Preclinical Data on Trodusquemine (MSI-1436) for the Treatment of Obesity at the American Diabetes Association 67th Scientific Session
10. Elixir Pharmaceuticals Presents Preclinical Data Highlighting Its Ghrelin Antagonist Program at the American Diabetes Associations Annual Meeting
11. DiObex Presents Phase 2a Data of DIO-902 Demonstrating Trends of Improved Glycemic Control and Significant Reductions of LDL-Cholesterol and C-Reactive Protein
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: InterMune Presents Research ITMN Hepatitis EASL Annual Meeting
(Date:8/27/2014)... Ltd. (NASDAQ: SVA ), a leading provider of biopharmaceutical ... of the Company,s 2014 Annual General Meeting of Shareholders held on ... The required quorum, a majority of the common shares outstanding, was ... following proposals:  , The re-election of Weidong Yin ... Kenneth Lee and Meng Mei as the Company,s ...
(Date:8/27/2014)... YORK and LONDON , Aug. 27, ... research solutions, MarketResearch.com is pleased to announce the ... Medical Devices Knowledge Center. The Medical ... the latest market research in the healthcare industry. ... reports from industry expert, Kalorama Information, published from ...
(Date:8/26/2014)... -- Intelomed is pleased to announce that Mary ... the Vice President of Clinical Affairs. With over 30 ... industry, Kay,s experience in taking medical technology and associated ... global expansion, is a valuable addition to the Intelomed ... our team, and I am confident her focused and ...
Breaking Medicine Technology:Sinovac Announces Results of 2014 Annual General Meeting of Shareholders 2MarketResearch.com: New Medical Devices Research Reports Added to Kalorama Information Knowledge Center 2MarketResearch.com: New Medical Devices Research Reports Added to Kalorama Information Knowledge Center 3Mary Kay Deck joins Intelomed as Vice President of Clinical Affairs 2
(Date:8/27/2014)... 27, 2014 Will Holbrook, CP LP, ... Will has over 15 years of experience in the ... Rome, Georgia with a Bachelor of Science degree with ... He received his graduate degree in prosthetics at ... to have Will join us at Fourroux,” says Keith ...
(Date:8/27/2014)... (HealthDay News) -- In a new study done from ... your blood pressure steadily increases if you ascend to ... widely used to treat high blood pressure was ineffective ... findings, reported online Aug. 27 in the European ... but those at sea level who have sleep apnea, ...
(Date:8/27/2014)... BESLER Consulting , a leading provider of ... pleased to announce that it has been named to ... The list represents the most comprehensive look at an ... "It's been an exciting year for our company and ... Inc. 5000 list,” said Jonathan Besler, BESLER’s President and ...
(Date:8/27/2014)... IL (PRWEB) August 27, 2014 The ... announce the recipients of the 2014-2016 Basic Research Fellowships ... early career scientists, the ABTA is seeding the field ... to change our understanding of the causes, effects, diagnosis ... selected by a scientific committee based on the potential ...
(Date:8/27/2014)... 2014) An experimental drug designed to help regulate the ... for anemia of inflammation, according to results from the first ... in Blood , the Journal of the ... condition that occurs when red blood cells are in short ... anemia, the body does not get enough oxygen, since there ...
Breaking Medicine News(10 mins):Health News:Everest Study Finds High Altitude Affects Blood Pressure 2Health News:BESLER Consulting Among America’s Fastest Growing Private Companies 2Health News:American Brain Tumor Association Awards New Research Grants to Best and Brightest Investigators 2Health News:American Brain Tumor Association Awards New Research Grants to Best and Brightest Investigators 3Health News:Drug represents first potential treatment for common anemia 2
... Aug. 13 Lilly MDR TB Partnership and Children International ... TB eradication in India. , , ... , Lilly MDR TB Partnership, with the support ... teen community with necessary resources to help reach out to ...
... to perceive feelings, study finds , THURSDAY, Aug. 13 ... to recognize other people,s facial emotions, a new study ... brain activity in 15 abstinent long-term alcoholics while they ... emotional expressions. The brain scans revealed decreased activation in ...
... treatment, prevention and detection behind progress, study finds , ... are declining, especially among younger people, new research shows. ... number one killer in the United States, topping heart ... decreased faster than for cancer. , "Older Americans have ...
... , , , , ... KAD ), a leading provider of home care, medical staffing, and pharmacy services ... ended June 30, 2009. , , For the ... with $26.8 million for the same period last year. Arcadia reported a ...
... , , New England ... Therapeutics Article; UFE Could Decrease Hysterectomy Rate in United States ... Uterine fibroid embolization--a minimally invasive interventional radiology treatment for women that ... highlighted as an appropriate treatment for women in a Clinical Therapeutics ...
... BALTIMORE, Aug. 13 To protect the health of ... and the Greater Baltimore Urban League have joined together to ... American Medical Association. , , In ... minorities, including African Americans, face significant barriers to health care, ...
Cached Medicine News:Health News:'Eli Lilly-Children International' Launches Teen Campaign to Reduce TB Cases in India 2Health News:'Eli Lilly-Children International' Launches Teen Campaign to Reduce TB Cases in India 3Health News:Boozing Blunts Ability to Read Faces 2Health News:Cancer Deaths Declining, Especially Among Young 2Health News:Cancer Deaths Declining, Especially Among Young 3Health News:Arcadia Resources Announces First Quarter Results 2Health News:Arcadia Resources Announces First Quarter Results 3Health News:Arcadia Resources Announces First Quarter Results 4Health News:Arcadia Resources Announces First Quarter Results 5Health News:Arcadia Resources Announces First Quarter Results 6Health News:Arcadia Resources Announces First Quarter Results 7Health News:Arcadia Resources Announces First Quarter Results 8Health News:Arcadia Resources Announces First Quarter Results 9Health News:Arcadia Resources Announces First Quarter Results 10Health News:Arcadia Resources Announces First Quarter Results 11Health News:Arcadia Resources Announces First Quarter Results 12Health News:Arcadia Resources Announces First Quarter Results 13Health News:Arcadia Resources Announces First Quarter Results 14Health News:Arcadia Resources Announces First Quarter Results 15Health News:Interventional Radiology Treatment for Uterine Fibroids: Safe, Nonsurgical Option 2Health News:Interventional Radiology Treatment for Uterine Fibroids: Safe, Nonsurgical Option 3Health News:Interventional Radiology Treatment for Uterine Fibroids: Safe, Nonsurgical Option 4Health News:Interventional Radiology Treatment for Uterine Fibroids: Safe, Nonsurgical Option 5Health News:Leading African American Groups Call On Health Insurers to Dismiss Restrictive Practices 2Health News:Leading African American Groups Call On Health Insurers to Dismiss Restrictive Practices 3
IDS Rapid NF Plus, a microbial identification system....
The Cogent Microbial Luminescence System (MLS) is a superior Rapid microbial detection system for UHT product screening combining proven technology of ATP-bioluminescence with unsurpassed hardware in...
Bax detection system is a fast and accurate test for screening food and environmental samples by breaking them down to genetic level, using the power of the polymerase chain reaction (PCR) to detect ...
A versatile plate washer and/or dispenser that aspirates from the top down without immersing the aspirating tubes in the well, ensuring overflow protection. 5 programmable protocols....
Medicine Products: